Lerner S - Search Results

1

Palou J, Baniel J, Klotz L, Wood D, Cookson M, Lerner S, Horie S, Schoenberg M, Angulo J, Bassi P. Palou J, et al. Among authors: lerner s. Urology. 2007 Jan;69(1 Suppl):50-61. doi: 10.1016/j.urology.2006.05.059. Urology. 2007. PMID: 17280908 Review.

2

The risk of dying of prostate cancer in patients with clinically localized disease.

Lerner SP, Seale-Hawkins C, Carlton CE Jr, Scardino PT. Lerner SP, et al. J Urol. 1991 Oct;146(4):1040-5. doi: 10.1016/s0022-5347(17)37997-1. J Urol. 1991. PMID: 1895420

3

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

4

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.

Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2001 Jan;57(1):60-5. doi: 10.1016/s0090-4295(00)00892-x. Urology. 2001. PMID: 11164145

5

Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer.

Belldegrun A, Bander NH, Lerner SP, Wood DP, Pantuck AJ. Belldegrun A, et al. Among authors: lerner sp. J Urol. 2001 Oct;166(4):1316-21. doi: 10.1016/s0022-5347(05)65760-6. J Urol. 2001. PMID: 11547065 Review.

6

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.

Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. Shariat SF, et al. J Urol. 2003 Mar;169(3):938-42. doi: 10.1097/01.ju.0000043638.89552.ed. J Urol. 2003. PMID: 12576817

7

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

8

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI. Lotan Y, et al. Among authors: lerner sp. J Clin Oncol. 2005 Sep 20;23(27):6533-9. doi: 10.1200/JCO.2005.05.516. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116151

9

Cancer specific outcomes in patients with pT0 disease following radical cystectomy.

Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP; Bladder Cancer Research Consortium. Palapattu GS, et al. Among authors: lerner sp. J Urol. 2006 May;175(5):1645-9; discussion 1649. doi: 10.1016/S0022-5347(05)00995-X. J Urol. 2006. PMID: 16600721

10

Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.

Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP. Rogers CG, et al. Among authors: lerner sp. J Urol. 2006 Jun;175(6):2048-53; discussion 2053. doi: 10.1016/S0022-5347(06)00317-X. J Urol. 2006. PMID: 16697800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

801 results

Search Page